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Abstract
INTRODUCTION—Prader-Willi syndrome (PWS) is caused by a deficiency of imprinted genes 
in the 15q11-q13 region and is characterized by prenatal-onset of hypotonia, poor feeding, 
childhood-onset obesity, hyperphagia, short stature, facial dysmorphism, intellectual disability, and 
behavioral problems. We studied perinatal factors in a cohort of 64 people with PWS resulting 
from paternal deletion of 15q11-q13 and maternal uniparental disomy for chromosome 15 (UPD).
METHODS—We recruited 34 individuals with deletion and 30 with UPD. We compared the 
frequency of multiple prenatal and neonatal factors with the general population as well as between 
the two genetic subtypes.
RESULTS—Of the 64 individuals with PWS, fetal movements were decreased in 82.8%, 31.7% 
were born prematurely, 42.1% by Cesarean section, and 35.9% required oxytocin induction, Apgar 
scores were low in 34.6%, 96.8% had feeding difficulty, 50% needed tube feeding, and 6.2% 
subsequently had gastrostomy tube placement. On comparing findings in the deletion versus the 
UPD groups, we did not find many significant differences. We however found a higher maternal 
age, and also later age at diagnosis in the UPD versus the deletion group.
CONCLUSION—PWS subjects have higher rates of perinatal complications, especially Cesarean 
section rate, hypotonia, and low Apgar scores compared to the general population. We did not find 
many differences between the genetic subtypes, except for later age of diagnosis of the UPD 15 
group suggesting a milder phenotype. We also found that the mothers in the UPD were older, 
supporting the hypothesis that UPD results from non-disjunction associated trisomy rescue.
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INTRODUCTION
PWS is a complex genetic disorder characterized by prenatal onset of hypotonia, infantile 
poor feeding and growth, hyperphagia with subsequent obesity, short stature, typical facial 
dysmorphism, psychomotor delay, behavioural abnormalities, and cognitive impairment. 
Deficiency of imprinted genes from the paternal 15q11-q13 is the cause of this 
neurodevelopmental disorder. The maternal copy of several genes in this region is typically 
inactive due to methylation, this parent of origin effect on gene expression being called 
genetic (or genomic) imprinting. PWS has three different molecular causes: a) deletion of 
the paternal copy of 15q11–13, present in approximately 70% of those with PWS, b) 
maternal uniparental disomy (UPD) for chromosome 15, in which both copies of 
chromosome 15 are maternally inherited with no paternally inherited region of chromosome 
15, accounting for approximately 28% of cases of PWS, and c) imprinting center defects 
accounting for 1–2% of those diagnosed with PWS [Driscoll et al.1998]. Differences 
between the frequencies of some clinical features have been identified between those with 
deletion and those with UPD as a cause of their PWS, though no feature is caused 
exclusively by only one of the genotypes [Driscoll et al.1998].
This study aimed to characterize the perinatal complications in a cohort of individuals with 
PWS and compare findings in the two most common genetic types: deletion and UPD. We 
review the literature on perinatal complications in PWS (Fong & De Vries, 2003) and also 
compared our findings with larger previous studies in France (Dudley & Muscatelli, 2007), 
(Bar et al., 2017), and the United Kingdom [Whittington et al. 2008]
METHODS
This research is part of a project started at Case Western Reserve University and continued 
at the University of California, Irvine. Institutional review board approval was obtained from 
University of California, Irvine for this study. Informed consent was obtained from the 
parents and assent from the patient if aged above 7 y. Affected subjects aged 3 y. to 
adulthood of both sexes were included in the study with no control population. Individuals 
needed confirmation of the diagnosis of PWS by molecular testing and were excluded if they 
only had a clinical diagnosis of PWS. Subjects were recruited either during patients visits, 
by letter or by telephone by the project coordinator. Subjects were assessed over three days 
for multiple historical and clinical parameters, including detailed history of the pregnancy, 
labor and delivery as obtained from parental report and available record review. The 
objective of this study was to collect a cohort with approximately equal numbers of 
individuals with PWS due to deletion and due to UPD, with the aim of studying phenotypic 
differences between the two genotype groups. The current project looked to assess the early 
manifestations, including pregnancy, delivery and early neonatal manifestations and 
compare it to the USA population data and between genotype groups. We reviewed perinatal 
clinical features including decreased fetal movements, polyhydramnios, malpresentation, 
and assisted vaginal deliveries with forceps or vacuum or invasive Cesarean section as well 
as neonatal features including birth weight, length, head circumference, Apgar scores, 
hypotonia, feeding difficulties, frequency of gavage feeding, and gastrostomy tube 
placement.
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ANALYSIS
The data was analysed using the JMP statistical package. Contingency tables were 
generated. Parametric variables were expressed as mean (±SD) while non parametric 
variables were expressed as median and range. Categorical variables were expressed as 
frequencies in each group. Student t -test was used to compare means. Non parametric 
variables were compared using Mann-Whitney U. Chi-square and Fisher exact test were 
used for categorical variables. All tests were 2-tailed with statistical significance considered 
at p <0.05.
RESULTS
Sixty-four patients participated in this study including 34 patients with deletions and 30 
patients with maternal UPD; this cohort including 34 males, (18 with deletion and 16 with 
UPD) and 30 females (16 with deletion and 14 with UPD). The mean age of diagnosis in the 
overall group was (4.9 y.) It was significantly later in the UPD group (5.8 y.) versus the 
deletion group (4.3 y.).
Data resulting from this study are summarized in Table 1. Maternal age was significantly 
higher in the UPD group (36.7± 4.3 y.) versus the deletion group (28.7 ± 3.5 y.) (p = 
0.0001). Fetal movements were reported as subjectively decreased in 53 subjects (82.8%). 
Only 8 mothers reported normal fetal movements, and these were equally distributed 
between the deletion and UPD groups. No statistical significance was found between the 
groups for timing of the delivery or birth weight in this study.
There was no statistically significant difference found between the UPD and deletion groups 
for incidence of Cesarean versus vaginal delivery. No statistical difference for the number of 
subjects having either a premature or post 42 week delivery between the genetic groups was 
noted (p = 0.75). The difference in the mean birth weight for those with deletion (n=29) was 
2.90 ± 0.61 kg and for UPD (n=29) was 2.86 kg ± 0.5), these differences not being 
significant (p=0.8), but there is high incidence of low birth weight at 18% versus 8% in 
United states in 2015 CDC report (Martin et al., 2017).
Of the 63 patients with perinatal information, 20 (31.7%) were born prematurely prior to 37 
weeks (11 deletion/ 9 had UPD),which is much higher prematurity rate of 9.6% for all the 
deliveries in United States in 2015 as reported by CDC (Martin et al., 2017), 23 were born at 
term (38 to 42 weeks) (11 deletion/12 UPD) and 20 were post term (>42 weeks) (10 
deletion/ 10 UPD). Among the 27 who had a Caesarean section (42.1%) 16 had deletion and 
11 had UPD. Among the 35 who had a vaginal delivery (54.4%), 23 requiring oxytocin 
induction (35.9%) (10 deletion/13 UPD) and only 12 (18.7%) had a normal spontaneous 
vaginal birth (7 deletion/5 UPD). The entire cohort (96.8%) except for two individuals had 
feeding problems at birth: 50% needed gavage feeding of whom four patients (6.2%) needed 
invasive gastrostomy tube placement. Comparison with prior studies of perinatal problems in 
PWS was also performed (Table 2).
We also categorized our PWS subjects into two groups based on the year of birth: Group 1 
included patients born prior to 1992 and Group 2 subsequent to 1992 when DNA testing by 
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methylation studies was available. The mean age of diagnosis for the group born after 1992 
was (3.4 y.± 0.9 y.) with a range from one month to 13 y., while the mean age of diagnosis 
for the group born before 1992 was (4.8 y.± 1.4 y.) with a range from one month to 26 y. The 
difference is statistically insignificant (Mann–Whitney U-test; P= 0.68).
DISCUSSION
Prader–Willi syndrome (PWS) is a complex neurobehavioral disorder that was first 
described in 1956 by Prader, Labhart and Willi (Prader, Labhart, & Willi, 1956). The clinical 
diagnosis of PWS is challenging, being based on a constellation of non-specific clinical 
features that change over time (Trifiro et al., 2003). Subtle diagnostic features that evolve 
over time and inappropriate choice of the initial molecular test have led to delayed diagnosis 
in earlier publications. The past few decades have witnessed diagnosis at earlier age due to 
increase in the availability of molecular diagnostic tests and improved awareness of PWS 
features (Bar et al., 2017), (Lionti, Reid, White, & Rowell, 2015). Interestingly however, the 
age of diagnosis continues to be delayed in some of the contemporary studies (Dobrescu, 
Chirita-Emandi, Andreescu, Farcas, & Puiu, 2016). This has driven a research interest in the 
perinatal features of PWS since early diagnosis and adequate management are crucial to 
prevent obesity and its medical consequences, and improve cognitive skills (Bar et al., 
2017). Butler 2017 (Butler, 2017) reported that fetal growth restriction, and decreased fetal 
movements are the most common perinatal features. Gross et al.(2015)(Gross, Rabinowitz, 
Gross-Tsur, Hirsch, & Eldar-Geva, 2015) confirmed similar findings on reviewing the 
obstetric records of 106 individuals with PWS compared to the general population. They 
recommended the use of DNA methylation test for prenatal genetic screening whenever 
combination of polyhydramnios and small for gestational age (Gross et al., 2015). Decreased 
fetal movements were added as one of the minor diagnostic criteria by Holm et al. (1993) 
(Holm et al., 1993). Decreased fetal movements were also seen in 85.6% of our study 
population which is similar to previous reports.
Although this study may have been affected by recall bias, there is clearly a high rate of 
pregnancy and delivery complications in babies with PWS. There is a significantly higher 
rate of Cesarean sections and induced labor compared with general population in the USA, 
regardless of the genetic etiology of the PWS.
Comparison with prior studies of perinatal problems in PWS is shown in Table 2. Dudley et 
al. (2007) found a significantly high rate of induced labor, prematurity, and Cesarean section 
and also found significantly higher rates of prematurity, induced labor and advanced 
maternal age in a UPD group relative to a deletion group (Dudley & Muscatelli, 2007). In 
our cohort, similar high rates of Cesarean section (42.1%), hypotonia (93.4%) and 
prematurity (31.7%) were observed but we did not find any statistically significant 
difference in subgroup analysis except for the advanced maternal age in the UPD group 
versus the deletion group. In concordance with our results,Whittington et al. (2008) did not 
find any significant differences between deletion and UPD groups in the above mentioned 
factors, including feeding difficulty. In contrast there were statistically significant 
differences for the mother's age at delivery and birth weight between both groups. UPD was 
positively correlated and deletion was negatively correlated with the two factors 
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(Whittington, Butler, & Holland, 2008). Bar et al. (2017) found also significantly higher 
maternal age in UPD group in comparison with non UPD. Our study found higher rate of 
prematurity , decreased fetal movements, and feeding difficulty (31.7%, 85.6%, 96.8%) 
respectively in comparison with the French study ( 20%, 27%, 84.4%) respectively (Bar et 
al., 2017).
The introduction of new molecular testing has permitted easy confirmatory diagnosis of 
100% of PWS patients. Several studies report a very early age at diagnosis compared to our 
study. Bar et al. (2017) reported that the earliest median age of diagnosis in France is 18 
days (Bar et al., 2017), with other studies reporting a mean age at diagnosis of one month, 
range ( 0.51– 4.98 months) (Smith et al., 2003), and 6.5 months with range from one week 
to 8 y. (Vogels & Fryns, 2004). Our study in contrast found a mean age of diagnosis of (4.9 
y. ± 5 y.) with range from one month to 26 y. If and when newborn screening for PWS is 
available, all genotypes will be picked up very early and early management and treatment 
will be available for all individuals with PWS. We also found that the age of diagnosis was 
significantly delayed in the UPD group to 5.8 y. ±1 y. These findings were reported by 
several other researchers including Gunay-Aygun et al. (1997) (Gunay-Aygun, Heeger, 
Schwartz, & Cassidy, 1997), Dykens et al. (2002) (Dykens, 2002),Hartley et al. (2005) 
(Hartley, Maclean, Butler, Zarcone, & Thompson, 2005) and Cassidy et al. (2012) (Cassidy, 
Schwartz, Miller, & Driscoll, 2012). This has be attributed to a milder phenotype with less 
typical facial features, milder behavioral problems, and higher verbal intelligence quotient in 
the UPD group leading to later diagnosis. In contrast, however, Dobrescu et al (2016) 
reported that individuals with non-deletion PWS were diagnosed at a relatively younger age 
comparison to those with deletions (6.7 y. ± 4.6 y. versus 8.11 y. ± 5.6 y. respectively) 
(Dobrescu et al., 2016).
Imprinted genes are increasingly thought to play a large part in fetal growth and 
development. This study adds supportive data to this theory as there are pre-delivery 
manifestations. This data supports the previously reported studies suggesting that there is 
severe disturbance in growth and neurodevelopment that starts in early fetal life (Dudley & 
Muscatelli, 2007).
The repeat Cesarean rate in the US is over 90% and it is not known from our data collection 
if any of the Cesarean in our patients were because of a previous Cesarean. The USA rates 
of Cesarean have been rising over the last decade. Many of the individuals in the current 
study were born prior to 2000, the year of birth ranging from 1963–1999. The overall rate of 
Cesarean has increased by 40% since 1996, an increase in the primary rate from 14.6% to 
20.6%. By 2004 this rate had increased to 29.1% according to the Division of Vital Statistics 
of the CDC. As all of the participants in our study were born before 1999, even at a 
conservative estimate of the USA rate of 20–25% the rate of Cesarean in the PWS group we 
studied is almost double the US population rate (Center for disease control and prevention, 
1981–2003; 1981).
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CONCLUSIONS
Our study highlights some of the perinatal complications of PWS in a cohort of US patients. 
These complications include hypotonia, decreased fetal movements, high Cesarean rate, 
induced labor, assisted vaginal delivery, prematurity, and feeding difficulties. The cause of 
these perinatal difficulties is not known, but may relate to the profound hypotonia that is 
universal in PWS. The perinatal problems might play a role in the development of 
characteristic early postnatal difficulties (lethargy, poor suck) and subsequent developmental 
manifestations. Further prospective natural history studies may help to answer these 
questions. Our study also demonstrates later age of diagnosis in the UPD group in 
comparison with the deletion group, which may be due to less typical clinical phenotype and 
highlights the need for implementing PWS screening to be part of any newborn screening 
program. We hope that better understanding of the perinatal features of PWS could help in 
early diagnosis and prevention of associated comorbidities.
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Table1
Comparison of perinatal factors in deletion versus uniparental disomy in Prader-Willi syndrome
Total= 64 Deletion (N=34) UPD (N=30) p-value
Gender
Male 34 (53.1%) 18 (52.9%) 16 (47%) 0.814
Female 30 (46.8%) 16 (53%) 14 (46%)
Gestational age(N=63)
Preterm <37 wks. 20 (31.7%) 11 (32%) 9 (30%) 0.750
Full term 23 (36.5%) 11 (32%) 12 (40)
Postdates >42wks 20 (31.7%) 10 (29.4%) 10 (33.3%)
Mean maternal age ± SD (y.) 30 ± 4.7 28.7 ± 3.5 36.7 ± 4.3 <0.001
Mean birth weight ± SD (grams) 2882 ± 0.56 2900 ± 0.61 2860 ± 0.50 0.811
Mean birth length ± SD (cms.) 49.5 ± 5.3 50.5 ± 2.7 48.4 ± 7.1 0.125
Gastrostomy 4 (6.2%) 1 (2.9%) 3 (10%) 0.270
Gavage feeding 32 (50%) 18 (52.9%) 16 (53.35) 0.821
Feeding problems after birth 62 (96.8%) 32 (94.1%) 30 (100%) 0.322
Cesarean section 27/64 (42.1%) 16/34 (47%) 11/30 (36.6%) 0.417
Hypotonia 54 (84.3%) 26 (76.4%) 28 (93.3%) 0.081
Age of diagnosis(y.) 4.9 ± 5 4.3 5.8 0.017
Mean age of onset of hyperphagia ±SD (y.) 2.7 ± 1.2 2.5 ± 0.75 2.9 ± 2 0.215
Mean one minute Apgar score ±SD 5.9 ± 2.3 6.7 ± 2 5.5 ± 2.4 0.374
Low Apgar Scores (<7) at one minute (60.7%) (35.3%) (64.7%) 0.442
Mean 5 minute Apgar score ±SD 7.8 ± 1.1 7.7 ± 1 8 ± 1.2 0.882
Low Apgar Scores (<7) at five minutes (34.6%) (44.4%) (55.6%) 0.189
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Table 2
Comparison with prior studies of perinatal problems in PWS
US (N=64) UK (N=46)
[Whittington Butler and Holland 
2008]
France (N=86)
[Dudley and Muscatelli 2007]
France (N=61)
[Bar et al 2017]
Decreased fetal movements 53 (85.6%) (67.4% ) (47.6%) (27%)
Preterm ≤ 37 wks. 20 (31.7%) (37%) (15%) (20%)
Induction 23 (35.9%) (37%) (60.4%)) NA
Vaginal delivery 35 (56.5%) (17.4%) (41.8%) (32.7%)
Caesarean Section 27 (42.1%) (52.2%) (53.4%) (67%)
Hypotonia 54 (84.3%) (100%) (96.5%) (76.1%)
Feeding difficulty 62 (96.8%) (100%) (82.5%) (84.4%)
Mean maternal age
Deletion 28.7 31.4 29.3 31
UPD 36.7 37.9 38
Mean one minute Apgar± SD 5.9 ± 2.3 7.40 ± 1.72 8.4 for deletion 7.6 ± 2.7
7.2 for UPD
Mean five minute Apgar ± SD 7.8 ± 1.1 8.79 ± 1.67 9.5 for deletion 9.2 ± 2
8.7 for UPD
NA = not available
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